Brostallicin: Phase Ib started

CTIC began a U.S. Phase Ib trial in patients to evaluate brostallicin in combination with either irinotecan or Avastin bevacizumab from Genentech Inc. (DNA, South San Francisco, Calif.) and Roche (...